Nephrotoxicity of continuous intravenous infusion of recombinant interleukin-2
- 1 June 1988
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 84 (6) , 1072-1075
- https://doi.org/10.1016/0002-9343(88)90314-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Renal, volume, and hormonal changes during therapeutic administration of recombinant interleukin-2 in manThe American Journal of Medicine, 1987
- Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced CancerAnnals of Internal Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Clinical effects and toxicity of interleukin-2 in patients with cancerCancer, 1986
- Intraperitoneal Administration of Interleukin-2 in Patients With CancerArchives of Surgery, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.The Journal of Immunology, 1985
- Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory AgentsMedicine, 1984
- Arachidonic acid metabolism, prostaglandins and the kidneyThe American Journal of Medicine, 1982